JP2024528169A - 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン - Google Patents

様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン Download PDF

Info

Publication number
JP2024528169A
JP2024528169A JP2024506483A JP2024506483A JP2024528169A JP 2024528169 A JP2024528169 A JP 2024528169A JP 2024506483 A JP2024506483 A JP 2024506483A JP 2024506483 A JP2024506483 A JP 2024506483A JP 2024528169 A JP2024528169 A JP 2024528169A
Authority
JP
Japan
Prior art keywords
serotype
streptococcus suis
antigen
suis
igm protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528169A5 (https=
Inventor
ジェイコブス，アントニウス・アーノルドゥス・クリスチャン
Original Assignee
インターベット インターナショナル ベー． フェー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー． フェー． filed Critical インターベット インターナショナル ベー． フェー．
Publication of JP2024528169A publication Critical patent/JP2024528169A/ja
Publication of JP2024528169A5 publication Critical patent/JP2024528169A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/2201—Streptopain (3.4.22.10)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2024506483A 2021-08-03 2022-06-29 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン Pending JP2024528169A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189283 2021-08-03
EP21189283.1 2021-08-03
PCT/EP2022/067892 WO2023011812A1 (en) 2021-08-03 2022-06-29 A vaccine for protection against streptococcus suis of various serotypes

Publications (2)

Publication Number Publication Date
JP2024528169A true JP2024528169A (ja) 2024-07-26
JP2024528169A5 JP2024528169A5 (https=) 2025-08-19

Family

ID=77206932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506483A Pending JP2024528169A (ja) 2021-08-03 2022-06-29 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン

Country Status (5)

Country Link
US (1) US20240325514A1 (https=)
EP (1) EP4380612A1 (https=)
JP (1) JP2024528169A (https=)
CN (1) CN117794563A (https=)
WO (1) WO2023011812A1 (https=)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
WO2013033092A2 (en) * 2011-09-03 2013-03-07 Boehringer Ingelheim Vetmedica Gmbh Streptococcus suis pilus antigens
WO2015181835A1 (en) 2014-05-30 2015-12-03 Naresh Laxminarayan Grover Mobile device with biometric, extra gps and alcohol sensor
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
US11155585B2 (en) 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
EP3359188A1 (en) * 2015-10-07 2018-08-15 Boehringer Ingelheim Vetmedica, Inc. Streptococcus suis polysaccharide-protein conjugate composition
RU2769573C2 (ru) * 2017-08-03 2022-04-04 Интервет Интернэшнл Б.В. Вакцина для защиты от streptococcus suis
RU2020119271A (ru) 2017-12-15 2022-01-17 Интервет Интернэшнл Б.В. Вакцина для защиты от streptococcus suis
ES3061725T3 (en) 2018-04-03 2026-04-07 Intervet Int Bv A vaccine for protection against streptococcus suis
WO2020094762A1 (en) 2018-11-08 2020-05-14 Intervet International B.V. A vaccine for protection against streptococcus suis
CN112402602A (zh) * 2020-11-09 2021-02-26 山东滨州沃华生物工程有限公司 一种四价猪链球菌病灭活疫苗佐剂、灭活疫苗及制备方法

Also Published As

Publication number Publication date
US20240325514A1 (en) 2024-10-03
CN117794563A (zh) 2024-03-29
WO2023011812A1 (en) 2023-02-09
EP4380612A1 (en) 2024-06-12

Similar Documents

Publication Publication Date Title
JP7571015B2 (ja) 豚レンサ球菌感染防御のためのワクチン
WO2019115741A1 (en) A vaccine for protection against streptococcus suis
US12383610B2 (en) Vaccine for protection against Streptococcus suis serotype 9, sequence type 16
JP7295223B2 (ja) 混合ワクチン
KR102819995B1 (ko) 연쇄상구균에 대한 보호를 위한 백신
WO2021073778A1 (en) Compositions and methods for vaccinating piglets against streptococcus
JP2024528169A (ja) 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
JP2024528172A (ja) 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
RU2841376C1 (ru) Вакцина для защиты от streptococcus suis серотипа 9, тип последовательности 16
JP2024527138A (ja) 様々な血清型のストレプトコッカス・スイスに対して保護するためのワクチン
RU2802072C2 (ru) Вакцина для защиты от streptococcus suis
RU2777065C1 (ru) Комбинированная вакцина
WO2025040792A1 (en) Multivalent vaccine against swine infections
WO2025040802A1 (en) New scheme of administration of a multivalent vaccine against swine infections

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250626

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250808